Align Technology, Inc. ALGN
- Market cap
- $10.4B
- P/E
- 25.5×
Follow ALGN
Align Technology, Inc. (ALGN) EV/Sales
As of 25 September 2026, Align Technology, Inc. (ALGN) trades at a EV/Sales of 2.3×. Over the past ten years it has ranged from 2.0× (September 2025) to 19.4× (February 2021); the current reading is higher than 2% of that period. That is below the Medical Instruments & Supplies industry median of 3.1× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Annual
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.5× | (30.39%) |
| FY2024 | 3.6× | (28.14%) |
| FY2023 | 5.1× | 21.38% |
| FY2022 | 4.2× | (67.43%) |
| FY2021 | 12.8× | (22.92%) |
| FY2020 | 16.6× | 88.05% |
| FY2019 | 8.8× | 8.52% |
| FY2018 | 8.2× | (30.43%) |
| FY2017 | 11.7× | 78.18% |
| FY2016 | 6.6× | 17.31% |
Quarterly
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.6× | (3.08%) |
| Mar 2026 | 2.7× | 7.68% |
| Dec 2025 | 2.5× | 25.33% |
| Sep 2025 | 2.0× | (37.51%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BAX Baxter International Inc. compare | 1.7× |
| BLCO Bausch + Lomb Corporation compare | 2.0× |
| AVTR Avantor, Inc. compare | 2.1× |
| ALGN Align Technology, Inc. | 2.3× |
| ATR AptarGroup, Inc. compare | 2.3× |
| SOLV Solventum Corporation compare | 2.4× |
| COO The Cooper Companies, Inc. compare | 3.1× |
| STVN Stevanato Group S.p.A. compare | 4.3× |
| RGEN Repligen Corporation compare | 13.4× |
| Medical Instruments & Supplies industry median | 3.1× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on ALGN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement